Omni McCluney
Medical · Houston, TXNPI 1689005860
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Pfizer at 42.5% of the total. Reporting peaked in 2024 at $8,775 and has fallen 60.6% since, to $3,454 in 2025. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $47.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$8K
- AbbVie$3K
- Sanofi$1K
- Eli Lilly$900
- Incyte Corporation$709
- E.r. Squibb & Sons, L.L.C.$691
- plus $4K from 18 others
What the payments were for
- Consulting fees$9005%
- Speaking & faculty fees$2,94017%
- Travel & lodging$3,32519%
- Food & beverage$9,81056%
- Education$6634%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 55 | $7,504 |
| AbbVie | 105 | $2,656 |
| Sanofi | 43 | $1,143 |
| Eli Lilly | 1 | $900 |
| Incyte Corporation | 16 | $709 |
| E.r. Squibb & Sons, L.L.C. | 23 | $691 |
| Johnson & Johnson | 19 | $678 |
| Amgen | 25 | $638 |
| LEO Pharma Inc. | 21 | $519 |
| Galderma Laboratories, L.p. | 19 | $414 |
| Sanofi-aventis U.S. LLC | 4 | $367 |
| Regeneron Healthcare Solutions, Inc. | 8 | $285 |
| Lilly USA, LLC | 13 | $279 |
| Journey Medical Corporation | 2 | $238 |
| Novartis | 8 | $197 |
| Sun Pharmaceutical Industries Inc. | 2 | $134 |
| Boehringer Ingelheim | 1 | $121 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Organon | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Sebela Pharmaceuticals Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,638 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 46 | $1,381 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 18 | $1,052 |
| Triamcinolone Acetonide | 21 | $705 |
| Cephalexin | 11 | $366 |
| Ketoconazole | 15 | $198 |
| Hydrocortisone | 12 | $69 |
| Fluconazole | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.